Literature DB >> 8311558

Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis.

R O Burney1, K D Pile, K Gibson, A Calin, L G Kennedy, P J Sinnott, S H Powis, B P Wordsworth.   

Abstract

OBJECTIVES: The evaluation of the role of polymorphism within the class II encoded antigen processing genes, LMP2 and TAP, in susceptibility to ankylosing spondylitis (AS).
METHODS: Eighty five patients with ankylosing spondylitis, 35 B27 positive healthy controls, and 55 unrelated healthy controls were studied. TAP1 and TAP2 alleles were assigned by ARMS PCR, and LMP2 alleles were assigned by restriction enzyme digestion of a PCR product.
RESULTS: The TAP1C allele was increased in the AS group (6%) compared with random controls (1%), p = 0.03 and TAP2E was increased in AS (3.5%) compared with random controls (0%), p = 0.05. However, the frequencies of these alleles were also increased in B27 matched controls. There were no differences in LMP2 allele or genotype frequencies between AS and either of the control groups. Partitioning of patients according to presence or absence of uveitis did not reveal any significant associations.
CONCLUSIONS: Increases of the minor TAP alleles, 1C and 2E, in AS reflect linkage disequilibrium between these alleles and HLA-B27. Polymorphism of the class I antigen processing pathway does not contribute significantly to AS susceptibility nor to the development of anterior uveitis associated with AS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311558      PMCID: PMC1005245          DOI: 10.1136/ard.53.1.58

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing.

Authors:  S Beck; A Kelly; E Radley; F Khurshid; R P Alderton; J Trowsdale
Journal:  J Mol Biol       Date:  1992-11-20       Impact factor: 5.469

2.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 3.  How do peptides associate with MHC class I molecules?

Authors:  T Elliott
Journal:  Immunol Today       Date:  1991-11

4.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

5.  HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients.

Authors:  W P Robinson; S M van der Linden; M A Khan; H U Rentsch; A Cats; A Russell; G Thomson
Journal:  Arthritis Rheum       Date:  1989-09

Review 6.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

7.  Analysis of the MHC-encoded transporters TAP1 and TAP2 in rheumatoid arthritis: linkage with DR4 accounts for the association with a minor TAP2 allele.

Authors:  B P Wordsworth; K D Pile; K Gibson; R O Burney; I Mockridge; S H Powis
Journal:  Tissue Antigens       Date:  1993-09

8.  Identification of a fourth class of proteins linked to the murine major histocompatibility complex.

Authors:  J J Monaco; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2.

Authors:  S H Powis; S Tonks; I Mockridge; A P Kelly; J G Bodmer; J Trowsdale
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

10.  Genetic modulation of antigen presentation by HLA-B27 molecules.

Authors:  L Pazmany; S Rowland-Jones; S Huet; A Hill; J Sutton; R Murray; J Brooks; A McMichael
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  7 in total

Review 1.  An update on the genetics of HLA B27-associated acute anterior uveitis.

Authors:  Tammy M Martin; James T Rosenbaum
Journal:  Ocul Immunol Inflamm       Date:  2011-04       Impact factor: 3.070

Review 2.  Genetic association between TAP1 and TAP2 polymorphisms and ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Yufeng Qian; Genlin Wang; Feng Xue; Lianghui Chen; Yan Wang; Liang Tang; Huilin Yang
Journal:  Inflamm Res       Date:  2017-04-12       Impact factor: 4.575

3.  Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: no association with disease severity.

Authors:  W P Maksymowych; N Adlam; D Lind; A S Russell
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

4.  The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis.

Authors:  W P Maksymowych; G S Jhangri; C Gorodezky; M Luong; C Wong; R Burgos-Vargas; M Morenot; J Sanchez-Corona; C Ramos-Remus; A S Russell
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

5.  Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis.

Authors:  W P Maksymowych; M Suarez-Almazor; C T Chou; A S Russell
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

6.  The LMP2 CfoI polymorphism is associated with ankylosing spondylitis (AS) risk but not with acute anterior uveitis (AAU): A meta-analysis.

Authors:  Yufeng Qian; Bingqian Chen; Xiaowen Sheng; Yuqin Peng
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis.

Authors:  Chen Zhang; Chen Wang; Zhenyu Jia; Wenwen Tong; Delin Liu; Chongru He; Xuan Huang; Weidong Xu
Journal:  Oncotarget       Date:  2017-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.